Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations

J Allergy Clin Immunol. 2023 Sep;152(3):815-817. doi: 10.1016/j.jaci.2023.05.016. Epub 2023 Jun 26.

¹ Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY.
² Pediatric Bone Marrow Transplant and Cellular Therapy Program, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY.
³ Department of Pediatrics, NYU Grossman School of Medicine and Hassenfeld Children's Hospital at NYU Langone, New York, NY.
⁴ Immune Discovery and Modeling Service, Sloan Kettering Institute, New York, NY.
⁵ Hematopoietic Stem Cell Transplant Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Mass.
⁶ Pediatric Bone Marrow Transplant and Cellular Therapy Program, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: [email protected].

No abstract available

Publication types